exalief
bial - portela ca, s.a. - eslicarbazepine acetate - epilepsy - antiepileptics, - exalief is indicated as adjunctive therapy in adults with partial-onset seizures with or without secondary generalisation.
sedoxil 1mg tablets
bial - portela & c s.a. À av. da siderurgia nacional, 4745-457 s. mamede do coronado, portugal - mexazolam - tablet - mexazolam 1 mg - psycholeptics
folicil, 5mg, tablet.
bial - portela & c s.a. À av. da siderurgia nacional, 4745-457 s. mamede do coronado, portugal - folic acid - tablet - folic acid 5 mg - antianemic preparations
folifer, 1mg + 90mg, film coated tablet
bial - portela & c s.a. À av. da siderurgia nacional, 4745-457 s. mamede do coronado, portugal - folic acid, iron - film-coated tablet - folic acid 1 mg iron 90 mg - antianemic preparations
diacol 1,8 mg/ml syrup
bial - portela & c s.a. À av. da siderurgia nacional, 4745-457 s. mamede do coronado, portugal - syrup - dextromethorphan hydrobromide 9 mg/5ml - cough and cold preparations
ongentys
bial - portela cª, s.a. - opicapone - parkinson disease - anti-parkinson drugs - ongentys is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.ongentys is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
cardipril 5mg tablets
bial - portela & c s.a. À av. da siderurgia nacional, 4745-457 s. mamede do coronado, portugal - imidapril hydrochloride - tablet - imidapril hydrochloride 5 mg - agents acting on the renin-angiotensin system
cardipril 10mg tablets
bial - portela & c s.a. À av. da siderurgia nacional, 4745-457 s. mamede do coronado, portugal - imidapril hydrochloride - tablet - imidapril hydrochloride 10 mg - agents acting on the renin-angiotensin system
ontilyv
bial portela & companhia s.a. - opicapone - parkinson disease - anti-parkinson drugs - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
antimicrobial susceptibility testing ivds
biomerieux australia pty ltd - ct1260 - antimicrobial susceptibility testing ivds - for determination of the antimicrobial susceptibility profile of microorganisms against a range of individual antimicrobial agents